Wealth Enhancement Advisory Services LLC Acquires 13,431 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Wealth Enhancement Advisory Services LLC increased its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 34.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 52,891 shares of the company's stock after acquiring an additional 13,431 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in Henry Schein were worth $3,660,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Smartleaf Asset Management LLC increased its holdings in shares of Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after purchasing an additional 143 shares during the period. Guggenheim Capital LLC grew its position in Henry Schein by 2.5% during the fourth quarter. Guggenheim Capital LLC now owns 6,428 shares of the company's stock worth $445,000 after buying an additional 159 shares in the last quarter. CIBC Asset Management Inc increased its stake in Henry Schein by 1.0% in the 4th quarter. CIBC Asset Management Inc now owns 17,849 shares of the company's stock worth $1,235,000 after acquiring an additional 169 shares during the last quarter. Metis Global Partners LLC boosted its position in shares of Henry Schein by 4.7% during the 4th quarter. Metis Global Partners LLC now owns 4,203 shares of the company's stock valued at $291,000 after acquiring an additional 187 shares during the last quarter. Finally, Sanctuary Advisors LLC grew its holdings in shares of Henry Schein by 5.0% during the fourth quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company's stock worth $294,000 after purchasing an additional 203 shares in the last quarter. Institutional investors own 96.62% of the company's stock.

Analyst Upgrades and Downgrades

HSIC has been the topic of a number of research analyst reports. Wall Street Zen lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Wells Fargo & Company dropped their price target on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Barrington Research reduced their price objective on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 6th. Piper Sandler dropped their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research report on Wednesday, April 30th. Finally, UBS Group reduced their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $79.30.

Henry Schein Trading Up 0.1%

NASDAQ:HSIC traded up $0.08 during trading hours on Thursday, hitting $70.47. The company had a trading volume of 865,137 shares, compared to its average volume of 1,680,131. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The stock has a 50-day moving average price of $67.71 and a 200 day moving average price of $71.68. The company has a market capitalization of $8.58 billion, a PE ratio of 29.00, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. During the same period last year, the company posted $1.10 EPS. The company's quarterly revenue was down .1% compared to the same quarter last year. On average, equities research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. The trade was a 6.05% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now directly owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. This trade represents a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.